High-fidelity Glucagon-CreER mouse line generated by CRISPR-Cas9 assisted gene targeting
Objective: α-cells are the second most prominent cell type in pancreatic islets and are responsible for producing glucagon to increase plasma glucose levels in times of fasting. α-cell dysfunction and inappropriate glucagon secretion occur in both type 1 and type 2 diabetes. Thus, there is growing i...
Main Authors: | Amanda M. Ackermann, Jia Zhang, Aryel Heller, Anna Briker, Klaus H. Kaestner |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-03-01
|
Series: | Molecular Metabolism |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877816303817 |
Similar Items
-
Tamoxifen-independent recombination in the RIP-CreER mouse.
by: Yanmei Liu, et al.
Published: (2010-10-01) -
Tamoxifen-Independent Recombination in the RIP-CreER Mouse
by: Solimena, Michele, et al.
Published: (2015) -
Comparison of the <i>Opn-CreER</i> and <i>Ck19-CreER</i> Drivers in Bile Ducts of Normal and Injured Mouse Livers
by: Bram Lesaffer, et al.
Published: (2019-04-01) -
Unexpected effects of ivermectin and selamectin on inducible CreER activity in mice
by: Peter A. Kropp, et al.
Published: (2020-10-01) -
New mouse lines for the analysis of neuronal morphology using CreER(T)/loxP-directed sparse labeling.
by: Tudor C Badea, et al.
Published: (2009-11-01)